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Studying freezing of gait (FOG) in the lab has proven problematic. -is has primarily been due to the diﬃculty in designing
experimental setups that maintain high levels of ecological validity whilst also permitting suﬃcient levels of experimental control.
To help overcome these challenges, we have developed a virtual reality (VR) environment with virtual doorways, a situation
known to illicit FOG in real life. To examine the validity of this VR environment, an experiment was conducted, and the results
were compared to a previous “real-world” experiment. A group of healthy controls (N� 10) and a group of idiopathic Parkinson
disease (PD) patients without any FOG episodes (N� 6) and with a history of freezing (PD-f, N� 4) walked under three diﬀerent
virtual conditions (no door, narrow doorway (100% of shoulder width) and standard doorway (125% of shoulder width)). -e
results were similar to those obtained in the real-world setting. Virtual doorways reduced step length and velocity while increasing
general gait variability. -e PD-f group always walked slower, with a smaller step length, and showed the largest increases in gait
variability. -e narrow doorway induced FOG in 66% of the trials, while the standard doorway caused FOG in 29% of the trials.
Our results closely mirrored those obtained with real doors. In short, this methodology provides a safe, personalized yet ad-
equately controlled means to examine FOG in Parkinson’s patients, along with possible interventions.
1. Introduction
Parkinson’s disease (PD) is a degenerative disease that is
characterized, in part, by the loss of dopamine-generating cells in
the basal ganglia [1]. -is lack of dopamine can cause brady-
kinesia (movement slowness), hypokinesia (reduced movement
amplitude), akinesia (problems initiating movement), tremor,
rigidity, and postural instability [2–4]. Approximately half of the
patients with advanced stages of PD experience freezing of gait
(FOG; [5]), a symptom where walking is interrupted by a brief,
episodic absence, or marked reduction, of forward progression
despite the intention to continue walking [3]. -is debilitating
symptom severely impairs mobility, hampers independence,
and increases the risk of falling [3, 4].
Although the causes of FOG episodes are multifaceted,
they often occur in response to certain environmental triggers
(e.g., doorways) thatmay ormay not require some kind of gait
adaptation (e.g., turning or slowing down [6–10]). In this
study, we aim to show how immersive, interactive virtual
reality (VR) technology can oﬀer a new methodological
framework for studying FOG in people with Parkinson’s. We
will examine how well this technology can allow us to ma-
nipulate the visual context to induce changes in gait char-
acteristics in PD patients who have and have not experienced
FOG episodes. Moreover, the use of an immersive, interactive
VR environment can allow us to determine the extent to
which diﬀerent visual scenes (e.g., doorways) can induce FOG
and impact gait performance.
Previous FOG-inducing protocols with a high level of
experimental control are very diﬀerent to how PD patients
normally experience episodes of FOG in real life (e.g., [11, 12])
and as a result have low ecological validity [13]. In contrast,
Hindawi
Parkinson’s Disease
Volume 2018, Article ID 2957427, 8 pages
https://doi.org/10.1155/2018/2957427
protocols that examine FOG in ecologically valid situations
(e.g., in the patient’s home [14]) usually suﬀer from limited
experimental control, compromising analytic rigor and the
subsequent interpretation of the data. A notable exception to
this is a study by Cowie et al. [15, 16], who asked their
participants to cross real doorways constructed and presented
in a laboratory setting and that were scaled to an individual
participant’s shoulder width. -is paradigm not only induced
episodes of FOG but ensured that a high level of ecological
validity and experimental control was maintained. In this
study, we will attempt to recreate this real-doorway par-
adigm in an immersive, interactive virtual reality envi-
ronment that not only preserves ecological validity [17] but
oﬀers enhanced possibilities for experimental manipulation
and control. Moreover, this technology also allows for the
quick and personalized manipulation of the information
delivered to each participant [18], yet oﬀering reproducibility
across trials.
-e objective of this study was to see if a virtual envi-
ronment with virtual doorways can induce FOG episodes in
Parkinson’s patients in the same way as real doorways
[15, 16]. To examine the eﬀectiveness of the virtual doorway
manipulation, we followed Cowie et al.’s protocol [15, 16]
and presented both narrow and standard doorways, com-
paring gait characteristics of PD patients with and without
a history of FOG to those of healthy controls. We expected to
ﬁnd similar results to Cowie et al. [15, 16], namely, reduced
step velocity, step length, and increased gait variability in
Parkinson’s patients, with the eﬀects being larger for patients
who have a history of FOG. It is also predicted that the FOG
group will experience more freezing episodes in conditions
with narrow doorways.
2. Methods
2.1. Participants. -ree groups of participants were recruited:
one group of healthy controls (HC; N� 10; mean
age� 63.0 yr.; SD� 8.6 yr; 6 females), one group of idiopathic
PD patients (PD; N� 6; mean age� 62.7 yr.; SD� 8.9 yr; 3
females), and a group of PD patients all of whom had a history
of FOG (PD-f;N� 4; mean age� 67.5 yr.; SD� 7.0; 2 females).
Motor disability was assessed using part III of the MDS-
UPDRS questionnaire [19]. “-e freezing of gait question-
naire” (FOGQ [20]) was used to assess if participants had
experienced FOG consistently in the week prior to the ex-
periment. A mean score >2 indicated that this was the case.
-e results of these tests are presented in Table 1, along with
demographic information about the PD participants. -e
study was approved by the university’s ethics committee.
2.2. Immersive, Interactive Virtual Reality. A virtual repre-
sentation of a hallway was presented to participants using an
Oculus Rift DK2 stereoscopic head-mounted display (Oculus
VR, Irvine, California, USA). -e screen had a resolution of
1920×1080, was updated 75 times per second, and had a ﬁeld
of view of 100°. To allow participants the freedom to walk up
and down the virtual hallway, the Intersense IS900 (InterSense
Inc., Bedford, Massachusetts, USA) tracking system was used
instead of the Oculus tracking (see Figure 1(a) for image of
a participant performing a trial). Both head position and
orientation were tracked and updated in the virtual environ-
ment at 120Hz. -e tracked space was 12m long by 5m wide.
-e virtual environment was constructed using the games
engine software Unity (version 5.4.1f1). -e environment
consisted of a virtual hallway 20m long and 2.5m high. In
order to increase the realism of the environment, a clay
texture was added to the walls and ceiling. Furthermore, to
make the ﬂoor look as realistic as possible a texture was also
added to make it look like a white carpet (Figure 2(a)).
-e width of the hallway was personalized for each
participant and was equivalent to 5 shoulder widths. Like-
wise, the width of the virtual doorways was also designed so
that they were directly related to the participant’s shoulder
width (Figure 2(b)). Shoulder width was a parameter that
was inputted at the start of each block of trials. -e par-
ticipants had to walk along the hallway between a red and
a yellow line which were positioned 6.5 meters apart.
2.3. Walking Metrics. To capture gait performance data,
participants had a rigid body containing three reﬂective
markers attached to the back of each shoe (Figure 1(b)). -e
movement of these reﬂective markers was recorded at
100Hz using 12 Qualisys infrared motion capture cameras
(Qualisys Ltd., Go¨teborg, Sweden). In order to allow
participants to see their own feet in the virtual environ-
ment, data were streamed in real-time from the infrared
motion capture system into the virtual environment
(Qualisys Unity SDK), 30 times a second. -e position of
the two rigid bodies was used to control the position and
orientation of two cuboids that were used to virtually
represent the position of the feet (Figure 2(c)).
2.4. Procedure. Before the start of the experiment, the
participant’s shoulder width was measured and entered into
Unity to scale the width of the virtual doorway and the
hallway to the participant’s own bodily proportions. -e
experiment was carried out by two experimenters. One
experimenter controlled the virtual environment and the
motion capture system while the other walked next to the
participant, holding the cable that connects the headset to
the computer, to ensure the participant’s safety. In accor-
dance with Cowie et al. [16], three conditions were created:
no virtual doorway (no door (ND)); a virtual doorway with
a width that corresponded to the participant’s own shoulder
width (narrow door (NaD)) or to 125% of the participant’s
shoulder width (standard door (StaD)).(Note that the large
door condition (150% shoulder width) that was included in
Cowie’s experiment was omitted from our study. It was
found not to induce any changes in gait characteristics nor
any FOG episodes in patients with an FOG history.) Sup-
plementary Video 1 of the supplementary material includes
an example of what a healthy control saw in the VR envi-
ronment while completing each of the three conditions.
Supplementary Video 2 includes an example of a healthy
control completing one trial in each of the three conditions.
2 Parkinson’s Disease
e three experimental conditions (ND, NaD, and StaD)
were randomly presented six times giving a total of 18 trials.
Before the start of the experiment, participants were given
a familiarisation phase, where they walked up and down the
virtual hallway eight times. Each time they were confronted
with doors with slightly dierent widths to the ones used in
the experimental trials.
In the conditions where a doorway was present, it was
placed 4 meters in front of the participant with the red or
yellow line indicating the end of the trial, positioned a further
2.5m beyond the doorway. In all conditions, the participants
were instructed to pass through the virtual doorway as they
would normally pass through a doorway in real life and walk
towards the yellow or red line in front of them. Once they
reached the line indicating the end of the trial, the trial au-
tomatically ended and participants, with the help of the ex-
perimenter, were asked to turn around and face the opposite
direction ready for the next trial. After each block of six trials,
the participants were allowed to rest for 2 minutes to again
minimise fatigue. e procedure lasted about 20 minutes.
2.5. Gait Analysis. For the conditions that involved
a doorway, the gait parameter analysis (step length, cadence,
and step velocity) was restricted to the area around the
doorway (3.5m before the doorway to 1m beyond the
doorway). For the no door (ND) condition, the same lo-
cation was used to ensure the walking distance analysed was
similar in all three conditions. e Qualisys data were
analysed using custom-made Matlab (Matlab 2016b;
Mathworks, Inc, Natick, Massachusetts, USA) routines.
After low-pass ltering the gait data (recursive Butterworth;
2nd order; cuto frequency: 10Hz), heel strikes were marked
automatically based on the moments at which the marker
nearest to the heel reached zero velocity in a vertical di-
rection. Step length was dened as the distance between two
successive heel strikes in the walking direction. Step cadence
was formalized as the number of steps taken each second.
Step velocity was calculated by dividing step length by the
time it took to complete that step. For each trial, the mean
and coecient of variation (CV; i.e., the ratio between the
standard deviation and the mean) was calculated.
HMD
(a)
Rigid bodies
(b)
Figure 1: (a) A participant performing a trial. e participant wore a head-mounted display (HMD). Two experimenters are present, one to
ensure the safety of the participant and another one to control the computer. (b)e two rigid bodies attached to the back of the shoes were
used to track the position of the feet.
Table 1: Demographic information about the PD participants.
Participant Age (years) Gender Years from diagnosis Clinical state UPDRS part III FOG-Q
PD1 61 Female 7 On 10 0.33 (0.51)
PD2 77 Male 6 O 29 0.66 (1.06)
PD3 64 Female 2 On 18 0.33 (0.52)
PD4 66 Female 4 On 37 0.5 (0.55)
PD5 50 Male 2 On 23 0.66 (1.03)
PD6 58 Male 7 On 27 0.66(1.03)
PD-f1 68 Female 6 O 35 3.00 (0.63)
PD-f2 76 Male 5 On 28 3.16 (0.43)
PD-f3 59 Female 4 On 36 2.66 (0.81)
PD-f4 69 Male 6 O 41 3.33 (0.51)
e clinical state is related to the eect of themedication: on responding well to medication; onot responding tomedication.e results of the FOGQ are
presented as the mean (SD) of all the results in the test. Participants PD1-6 idiopathic PD group; PD-f1–f4  PD participants that have experienced freezing
in the past.
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To determine whether FOG was induced in the PD-f
group, we followed the analysis of Cowie et al. [16] which is
based solely on step velocity. According to this method, FOG
episodes were deﬁned as sections of a trial where step ve-
locity dropped below 10% of the mean velocity obtained for
the same participant in the ND condition. If there were fewer
than three strides between two identiﬁed FOG episodes,
these two episodes were considered to reﬂect a single FOG
episode. For each PD-f participant, we determined the
percentage of trials in which FOG episodes were detected, as
well as the mean duration of these episodes and the re-
spective standard deviation.
2.6. Statistical Analysis. All statistical analyses were con-
ducted using RStudio (RStudio 1.138; RStudio, Inc., Bos-
ton, MA). Two-way mixed ANOVAs with the between-
subjects factor being group (HC, PD, and PD-f ) and the
within-subjects factor being door (ND, NaD, and StaD)
were carried out on the means and CVs of the three gait
parameters. -e results were considered signiﬁcant if p was
less than 0.05. Post hoc comparisons were based on simple
eﬀects analysis [21] and (if required) pairwise t-tests with
Bonferroni correction were used. -e size of the eﬀect was
also presented using the ωp2 that is believed to be a better
estimate of the size of the eﬀect than ηp2 [22]. -is statistic
can take values from 0 to 1, higher values indicating
a higher eﬀect size.
Kruskal–Wallis tests with a within-subject factor door
(ND, NaD, and StaD) were conducted on the percentage of
FOG episodes in the PD-f group. -e results were consid-
ered signiﬁcant if p was less than 0.05. If needed, post hoc
Dunn tests with Bonferroni corrections were carried out to
test for signiﬁcant main eﬀects. Mean durations of these
episodes and respective standard deviations were not sub-
mitted for statistical analysis.
3. Results
3.1. Gait Parameters
3.1.1. Mean Gait Parameter Values. -e ANOVA results for
step length (Figure 3(a)) and step velocity were similar. In
both cases, the main eﬀect of door was signiﬁcant (step
length: F(2,34) � 68.34, p< 0.001, ωp2 � 0.180; step velocity:
F(2,34) � 67.45, p< 0.001, ωp2 � 0.178). Post hoc analyses
revealed a signiﬁcantly smaller step length and lower step
velocity in the NaD condition compared to the ND con-
dition (Figure 3(c)). For both gait parameters, the eﬀect of
group was also signiﬁcant (step length: F(2,17) � 5.08,
(a) (b)
(c)
Figure 2: (a)-e no doorway (ND) condition along with the red line indicating the end of the trial in that direction, (b) the narrow doorway
(NaD) condition, and (c) a visual representation of the two cuboids that represent the placement of the participant’s feet in the virtual
environment (note that the image is captured from behind the participant).
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FIGURE 3: Results for step length (a), step cadence (b), step velocity (c), step length CV (d), step cadence CV (e), and step velocity CV (f) for
the three groups, for the three dierent door conditions. e data for step length are presented in meters. e data of step cadence are
presented in hertz that can be understood as the number of steps per second. Finally, the data for the step velocity are presented inmeters per
second (m/s). e error bars represent the standard error of the mean.
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p � 0.018, ωp2 � 0.026; step velocity: F(2,17) � 5.51, p � 0.014,
ωp2 � 0.028), with post hoc analyses showing that both pa-
rameters were signiﬁcantly smaller in the PD-f group than in
the two other groups. For step cadence (Figure 3(b)), no
signiﬁcant eﬀects were obtained.
3.1.2. Variability (CV) of the Gait Parameters. -e results of
the three ANOVAs that were conducted on the gait parameter
CVs also showed close correspondence. In all cases, main
eﬀects were obtained for door (step length CV: F(2,34) � 36.87,
p< 0.001, ωp2 � 0.105; step cadence: F(2,34) � 10.20, p< 0.001,
ωp2 � 0.044; step velocity: F(2,34)� 34.51 p< 0.001, ωp2� 0.099)
and group (F(2,17)� 4.07, p � 0.036, ωp2 � 0.020; F(2,17) � 5.65,
p � 0.013, ωp2� 0.029; F(2,17) � 5.26 p � 0.017, ωp2 � 0.028,
resp.),while the interaction between these two factors was also
signiﬁcant (F(4,37) � 3.08, p � 0.029, ωp2 � 0.015; F(4,37) � 3.48,
p � 0.017; ωp2 � 0.017; F(4,37) � 3.13, p � 0.027; ωp2� 0.015,
resp.). For step length CV (Figure 3(d)) and step velocity
CV (Figure 3(f )), post hoc analysis of the eﬀect of door
revealed that variability was larger in the NaD condition
compared to the other two conditions. For step cadence CV
(Figure 3(e)), variability in the NaD condition was larger
than in the ND condition. -e group eﬀect was similar for
all three CVs, showing higher variability for the PD-f group
than for the other two groups. -e door x group interaction
was also similar for all three CVs, indicating that in the PD-f
group, all door conditions diﬀered signiﬁcantly from one
another, while in the other two groups the diﬀerence was
signiﬁcant only between the NaD and ND conditions. -e
analysis indicated that there was no signiﬁcant diﬀerence
between groups in the ND condition, but the diﬀerence
between the PD-f group and the other groups was signiﬁcant
for both the NaD and the StaD doorways.
3.2. Freezing Episodes. Table 2 presents, per condition, the
percentage of trials in which FOG episodes were detected for
the individual participants who made up the PD-f group,
along with information regarding the durations of these
FOG episodes. -e NaD condition induced at least one FOG
episode in all four patients, with FOG occurring in all of the
NaD trials for two of the participants (PD-f1 and PD-f4).
-e StaD condition was less eﬀective in this regard, but still
induced FOG in 83% of the trials in PD-f4 and 33% of the
trials in PD-f1. -e Kruskal–Wallis test yielded a signiﬁ-
cant eﬀect for the factor door (χ2 � 24.32 p< 0.001). Post
hoc analysis revealed that the three door conditions were
signiﬁcantly diﬀerent, with the NaD condition (66%) in-
ducing more FOG episodes than the StaD condition (29%)
which in turn caused more FOG episodes than the ND
condition (4%). Supplementary Video 3 shows PD-f1
completing a trial in each doorway condition and illus-
trates how both doorway conditions cause her to expe-
rience a FOG episode.
4. Discussion
We developed an immersive, interactive VR environment
that was used to manipulate the visual context within which
participants control their walking along a virtual hallway.
-e technology not only allows us to systematically ex-
amine how environmental changes such as the presence of
virtual doorways of diﬀerent widths inﬂuences various gait
characteristics, but also how these visual changes inﬂuence
the number of FOG episodes participants with Parkinson’s
disease experience. By using the power of VR to recreate
real-life situations commonly known to induce FOG
(namely narrow doorways), we were able to measure the
eﬀects these doorways had on a participant’s gait. Overall,
the results obtained in our VR environment were very
similar to those found in the studies conducted by Almeida
and Lebold [23] and Cowie et al. [15] who used real-life
stimuli. In sum, the PD-f group walked slower with smaller
steps and demonstrated a higher degree of gait variability
than the other two groups. When confronted with narrow
doorways, all groups reduced speed and step length,
compared to the condition in which no doorway was
presented.
A further validation of our method was the fact that the
narrow doorway elicited higher degrees of gait variability
for all groups of participants compared to the condition
without a door. Moreover, our virtual doorways induced
Table 2: Characteristics of induced FOG episodes for each participant in the PD-f group as a function of door condition.
Participants Doorcondition
% trials with an
FOG episode
Mean duration of an
FOG episode
Max duration of an
FOG episode
Min duration of an
FOG episode
PD-f1
No door 0 NA NA NA
Standard door 33 5.64 s± 4.07 s 8.972 s 0.51 s
Narrow door 100 7.64 s± 5.26 s 17.93 s 1.00 s
PD-f2
No door 0 NA NA NA
Standard door 0 NA NA NA
Narrow door 16 1.00 s± 0.00 s 1.00 s 1.00 s
PD-f3
No door 0 NA NA NA
Standard door 0 NA NA NA
Narrow door 50 0.61 s± 0.23 s 0.87 s 0.45 s
PD-f4
No door 16 0.85 s± 0.00 s 0.85 s 0.85 s
Standard door 83 2.85 s± 3.71 s 9.45 s 0.85 s
Narrow door 100 3.1 s± 1.68 s 6.35 s 1.97 s
-e results include percentage of trials in which patients experienced FOG; mean duration of these episodes (including standard deviation); and maximum
and minimum duration of the episodes. NA indicates that no FOG episode was observed.
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freezing-like episodes in the majority of our PD-f patients.
-ese episodes ranged from 1 s to 18 s, with a median of
around 8 s. All of these participants had more freezing
episodes when presented with the narrow doorway com-
pared to the standard doorway. -ese ﬁndings clearly
demonstrate how the visual information presented in the
virtual environment inﬂuences gait in the same way as real
doorways [16].
-e close correspondence between our current results
and those obtained in experiments using real doorways,
speaks to the high levels of behavioural realism and eco-
logical validity induced by the VR environment. What is
interesting about this technology is that it can be easily used
to examine gait in Parkinson’s disease but also be used to
successfully induce FOG episodes in a patient population.
Moreover, VR environments can not only be used to assess
the symptoms of PD, but also to test the eﬀects potential
interventions may have on improving quality of life in
a safe and systematic way. For instance, the eﬀectiveness of
speciﬁc forms of visual cueing [24], to reduce FOG and
improve Parkinsonian gait, may be readily examined in
a VR environment. -is also holds true for testing visual
cueing techniques that use augmented reality glasses
[25–27] which may ultimately oﬀer a more practical ap-
plication for adding virtual cues to real-life conditions.
Other lines of research may also focus on the development
of ecologically valid, immersive VR environments that are
representative of other problematic situations for PD pa-
tients (like initiating gait or turning) and test potential
intervention strategies that can be personalized to meet the
needs of the individual participant.
In conclusion, immersive, interactive virtual reality is an
exciting methodology that allows for the preservation of the
perception/action loop. By controlling the presentation of
sensory information (e.g., visual context), we can system-
atically and accurately measure the eﬀects on diﬀerent
movement behaviours.
Data Availability
-e underlying data are available for anyone who asks for it.
Please send an email to luis.jordana.martin@gmail.com.
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Supplementary Materials
Supplementary 1. Video 1 shows what the participants saw in
the VR environment while they completed one trial of each
of the three conditions of the experiment.
Supplementary 2. Video 2 shows a healthy participant
performing one trial of each condition.
Supplementary 3. Video 3 contains a video of a PD par-
ticipant performing one trial of each condition. -e body
of the article explicitly states when should the videos be
watched.
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